Advertisement

Topics

Ocular cuts jobs post FDA rejection

07:50 EDT 3 Aug 2017 | in-PharmaTechnologis

Ocular Therapeutix has announced it is laying off 19% of its workforce in order to cut operating expenses.

Original Article: Ocular cuts jobs post FDA rejection

NEXT ARTICLE

More From BioPortfolio on "Ocular cuts jobs post FDA rejection"

Quick Search
Advertisement